Clicky

Biofrontera Inc.(BFRI)

Description: Biofrontera Inc., a biopharmaceutical company, develops and provides dermatological products for the treatment of skin diseases in the United States. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz, an aminolevulinic acid hydrochloride gel for the photodynamic therapy of actinic keratoses; and BF-RhodoLED, an LED lamp emitting red light for use in photodynamic therapy. The company was founded in 1997 and is based in Woburn, Massachusetts.


Keywords: Medicine Biopharmaceutical Clinical Medicine Health Sciences Medical Physics Melanoma Dermatology Antineoplastic Drugs Skin Diseases Laser Medicine Light Therapy Actinic Keratosis Dermatological Products Treatment Of Skin Diseases Photodynamic Therapy Ameluz Non Melanoma Skin Cancer

Home Page: www.biofrontera-us.com

BFRI Technical Analysis

120 Presidential Way
Woburn, MA 01801
United States
Phone: 781-245-1325


Officers

Name Title
Dr. Hermann Lubbert Ph.D. Exec. Chairman & Pres
Ms. Erica L. Monaco CPA CEO, COO, Treasurer & Sec.
Mr. Eugene Fredrick Leffler III Chief Financial Officer
Ms. Erica F. Gates CPA, M.B.A. Sr. Director of Fin. & Principal Accounting Officer
Ms. Alycia Torres VP of Admin.
Mr. Daniel Hakansson J.D. Gen. Counsel & Head of Compliance
Mr. Mark Baldyga Head of Sales & Marketing
Mr. Jeff Holm Head of Professional Relations & Commercial Devel.

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.1282
Price-to-Sales TTM: 0.8579
IPO Date: 2021-10-29
Fiscal Year End: December
Full Time Employees: 69
Back to stocks